Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

NCT05523947 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-Positive Solid Tumor

Interventions

DRUG: YH32367

Sponsor

Yuhan Corporation